No Guarantees: Planned Oocyte Cryopreservation, Not Quite an Insurance Policy

Overview

Journal Arch Gynecol Obstet

Specialty Gynecology & Obstetrics

Date 2024 Aug 3

PMID 39096366

Authors

Sigal Klipstein

Lindsay Kelly

Sasmira Lalwani

Affiliations

Soon will be listed here.

Abstract

Planned oocyte cryopreservation (OC) has the potential to address the burden of the biological clock, giving women and individuals with ovaries more autonomy in choosing when to have children and with whom. In the United States, the annual number of OC cycles has grown significantly, yet many questions remain regarding planned OC. The field is starting to gather data on the clinical practice and social perspectives around planned oocyte cryopreservation, including the optimal age range at which to offer planned OC, what factors are most predictive of a successful outcome, and the optimal number of oocytes and ovarian stimulation cycles to achieve a live birth. There is a clear need for setting realistic expectations about the chance of success with OC; however, most patients have yet to return to thaw their oocytes, and outcomes data are limited. Clinical models have been developed to predict OC success based on surrogate markers such as age, number of oocytes retrieved, and anti-Müllerian hormone level. Patient education should emphasize the age-related decline in fertility, that eggs do not equal embryos, and that more than one cycle may be needed to obtain sufficient oocytes to have a reasonable chance of future success. While planned OC is not quite an insurance policy against future reproductive challenges, it provides the best option to date for expanding the reproductive window and maximizing reproductive options while navigating individual life circumstances in the context of family building.

References

Martin J, Osterman M . Changes in Prenatal Care Utilization:United States, 2019-2021. Natl Vital Stat Rep. 2023; 72(4):1-14. View

Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N . What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility?. Fertil Steril. 2013; 100(5):1343-9. DOI: 10.1016/j.fertnstert.2013.07.201. View

Tsafrir A, Holzer H, Miron-Shatz T, Eldar-Geva T, Gal M, Ben-Ami I . 'Why have women not returned to use their frozen oocytes?': a 5-year follow-up of women after planned oocyte cryopreservation. Reprod Biomed Online. 2021; 43(6):1137-1145. DOI: 10.1016/j.rbmo.2021.08.026. View

Armstrong A, Woods M, Keomany J, Grainger D, Shah S, Pavone M . What do female medical students know about planned oocyte cryopreservation and what are their personal attitudes?. J Assist Reprod Genet. 2023; 40(6):1305-1311. PMC: 10310635. DOI: 10.1007/s10815-023-02845-5. View

Johnston M, Richings N, Leung A, Sakkas D, Catt S . A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Hum Reprod. 2020; 36(3):624-635. DOI: 10.1093/humrep/deaa320. View

Huttler A, Koelper N, Mainigi M, Gracia C, Senapati S . Impact of the COVID-19 pandemic on the perception of planned oocyte cryopreservation in the United States. F S Rep. 2022; 3(2):145-152. PMC: 9065715. DOI: 10.1016/j.xfre.2022.04.008. View

Greenwood E, Pasch L, Hastie J, Cedars M, Huddleston H . To freeze or not to freeze: decision regret and satisfaction following elective oocyte cryopreservation. Fertil Steril. 2018; 109(6):1097-1104.e1. DOI: 10.1016/j.fertnstert.2018.02.127. View

Jaswa E, Pasch L, McGough A, Wong R, Corley J, Cedars M . Decision regret among women considering planned oocyte cryopreservation: a prospective cohort study. J Assist Reprod Genet. 2023; 40(6):1281-1290. PMC: 10310667. DOI: 10.1007/s10815-023-02789-w. View

Frederiksen L, Ernst A, Brix N, Lauridsen L, Roos L, Ramlau-Hansen C . Risk of Adverse Pregnancy Outcomes at Advanced Maternal Age. Obstet Gynecol. 2018; 131(3):457-463. DOI: 10.1097/AOG.0000000000002504. View

10.

Hartwig T, Sorensen S, Jorgensen F . The maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014. Prenat Diagn. 2016; 36(7):643-9. DOI: 10.1002/pd.4833. View

11.

Magnus M, Wilcox A, Morken N, Weinberg C, Haberg S . Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019; 364:l869. PMC: 6425455. DOI: 10.1136/bmj.l869. View

12.

Reddy U, Ko C, Willinger M . Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am J Obstet Gynecol. 2006; 195(3):764-70. DOI: 10.1016/j.ajog.2006.06.019. View

13.

Waldenstrom U, Cnattingius S, Vixner L, Norman M . Advanced maternal age increases the risk of very preterm birth, irrespective of parity: a population-based register study. BJOG. 2016; 124(8):1235-1244. DOI: 10.1111/1471-0528.14368. View

14.

Goldman R, Racowsky C, Farland L, Munne S, Ribustello L, Fox J . Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod. 2017; 32(4):853-859. DOI: 10.1093/humrep/dex008. View

15.

Fouks Y, Sakkas D, Bortoletto P, Penzias A, Seidler E, Vaughan D . Utilization of Cryopreserved Oocytes in Patients With Poor Ovarian Response After Planned Oocyte Cryopreservation. JAMA Netw Open. 2024; 7(1):e2349722. PMC: 10762568. DOI: 10.1001/jamanetworkopen.2023.49722. View

16.

Murphy H, Compton S, Moravek M, Rosen M . Impact of employer-covered planned oocyte cryopreservation on decision-making for medical training. J Assist Reprod Genet. 2023; 41(2):385-407. PMC: 10894800. DOI: 10.1007/s10815-023-02990-x. View

17.

Cascante S, Blakemore J, DeVore S, Hodes-Wertz B, Fino M, Berkeley A . Fifteen years of autologous oocyte thaw outcomes from a large university-based fertility center. Fertil Steril. 2022; 118(1):158-166. DOI: 10.1016/j.fertnstert.2022.04.013. View

18.

Cascante S, Berkeley A, Licciardi F, McCaffrey C, Grifo J . Planned oocyte cryopreservation: the state of the ART. Reprod Biomed Online. 2023; 47(6):103367. DOI: 10.1016/j.rbmo.2023.103367. View

19.

Leung A, Baker K, Vaughan D, Shah J, Korkidakis A, Ryley D . Clinical outcomes and utilization from over a decade of planned oocyte cryopreservation. Reprod Biomed Online. 2021; 43(4):671-679. DOI: 10.1016/j.rbmo.2021.06.024. View

20.

Tsafrir A, Hirsch A . Reply: What is the expected live birth rate per thawed oocyte?. Hum Reprod Update. 2024; 30(5):650. DOI: 10.1093/humupd/dmae014. View